Literature DB >> 14648284

Bone tissue incorporates in vitro gallium with a local structure similar to gallium-doped brushite.

M Korbas1, E Rokita, W Meyer-Klaucke, J Ryczek.   

Abstract

During mineral growth in rat bone-marrow stromal cell cultures, gallium follows calcium pathways. The dominant phase of the cell culture mineral constitutes the poorly crystalline hydroxyapatite (HAP). This model system mimics bone mineralization in vivo. The structural characterization of the Ga environment was performed by X-ray absorption spectroscopy at the Ga K-edge. These data were compared with Ga-doped synthetic compounds (poorly crystalline hydroxyapatite, amorphous calcium phosphate and brushite) and with strontium-treated bone tissue, obtained from the same culture model. It was found that Sr(2+) substitutes for Ca(2+) in the HAP crystal lattice. In contrast, the replacement by Ga(3+) yielded a much more disordered local environment of the probe atom in all investigated cell culture samples. The coordination of Ga ions in the cell culture minerals was similar to that of Ga(3+), substituted for Ca(2+), in the Ga-doped synthetic brushite (Ga-DCPD). The Ga atoms in the Ga-DCPD were coordinated by four oxygen atoms (1.90 A) of the four phosphate groups and two oxygen atoms at 2.02 A. Interestingly, the local environment of Ga in the cell culture minerals was not dependent on the onset of Ga treatment, the Ga concentration in the medium or the age of the mineral. Thus, it was concluded that Ga ions were incorporated into the precursor phase to the HAP mineral. Substitution for Ca(2+ )with Ga(3+) distorted locally this brushite-like environment, which prevented the transformation of the initially deposited phase into the poorly crystalline HAP.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14648284     DOI: 10.1007/s00775-003-0497-9

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  25 in total

1.  Effect of gallium on the in vitro formation, growth, and solubility of hydroxyapatite.

Authors:  N C Blumenthal; V Cosma; S Levine
Journal:  Calcif Tissue Int       Date:  1989-08       Impact factor: 4.333

2.  A pharmacokinetic and phase II study of gallium nitrate in patients with non-small cell lung cancer.

Authors:  L K Webster; I N Olver; K H Stokes; R G Sephton; B L Hillcoat; J F Bishop
Journal:  Cancer Chemother Pharmacol       Date:  2000       Impact factor: 3.333

Review 3.  Treatment of malignant hypercalcaemia.

Authors:  J Hurtado; P Esbrit
Journal:  Expert Opin Pharmacother       Date:  2002-05       Impact factor: 3.889

4.  Incorporation and distribution of strontium in bone.

Authors:  S G Dahl; P Allain; P J Marie; Y Mauras; G Boivin; P Ammann; Y Tsouderos; P D Delmas; C Christiansen
Journal:  Bone       Date:  2001-04       Impact factor: 4.398

5.  Temporal changes of mRNA expression of matrix proteins and parathyroid hormone and parathyroid hormone-related protein (PTH/PTHrP) receptor in bone development.

Authors:  H Kondo; T Ohyama; K Ohya; S Kasugai
Journal:  J Bone Miner Res       Date:  1997-12       Impact factor: 6.741

6.  Effect of gallium nitrate in vitro and in normal rats.

Authors:  L G Jenis; C E Waud; G S Stein; J B Lian; D T Baran
Journal:  J Cell Biochem       Date:  1993-07       Impact factor: 4.429

7.  Gallium nitrate increases type I collagen and fibronectin mRNA and collagen protein levels in bone and fibroblast cells.

Authors:  R S Bockman; P T Guidon; L C Pan; R Salvatori; A Kawaguchi
Journal:  J Cell Biochem       Date:  1993-08       Impact factor: 4.429

Review 8.  Gallium in cancer treatment.

Authors:  Philippe Collery; Bernhard Keppler; Claudie Madoulet; Bernard Desoize
Journal:  Crit Rev Oncol Hematol       Date:  2002-06       Impact factor: 6.312

9.  Characterization of very young mineral phases of bone by solid state 31phosphorus magic angle sample spinning nuclear magnetic resonance and X-ray diffraction.

Authors:  J E Roberts; L C Bonar; R G Griffin; M J Glimcher
Journal:  Calcif Tissue Int       Date:  1992-01       Impact factor: 4.333

10.  An intermediate state in hydrolysis of amorphous calcium phosphate.

Authors:  M S Tung; W E Brown
Journal:  Calcif Tissue Int       Date:  1983-09       Impact factor: 4.333

View more
  4 in total

Review 1.  Diffraction techniques and vibrational spectroscopy opportunities to characterise bones.

Authors:  D Bazin; C Chappard; C Combes; X Carpentier; S Rouzière; G André; G Matzen; M Allix; D Thiaudière; S Reguer; P Jungers; M Daudon
Journal:  Osteoporos Int       Date:  2009-06       Impact factor: 4.507

2.  Biocompatible hydroxyapatite nanoparticles as a redox luminescence switch.

Authors:  Hongyan Liu; Pinxian Xi; Guoqiang Xie; Fengjuan Chen; Zhenpeng Li; Decheng Bai; Zhengzhi Zeng
Journal:  J Biol Inorg Chem       Date:  2011-07-19       Impact factor: 3.358

3.  Antibacterial properties of poly (octanediol citrate)/gallium-containing bioglass composite scaffolds.

Authors:  Ehsan Zeimaran; Sara Pourshahrestani; Ivan Djordjevic; Belinda Pingguan-Murphy; Nahrizul Adib Kadri; Anthony W Wren; Mark R Towler
Journal:  J Mater Sci Mater Med       Date:  2015-12-16       Impact factor: 3.896

Review 4.  Gallium containing bioactive materials: A review of anticancer, antibacterial, and osteogenic properties.

Authors:  Fatih Kurtuldu; Nurshen Mutlu; Aldo R Boccaccini; Dušan Galusek
Journal:  Bioact Mater       Date:  2022-01-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.